SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-001363
Filing Date
2023-01-06
Accepted
2023-01-06 16:05:42
Documents
15
Period of Report
2023-01-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea171330-8k_dominari.htm   iXBRL 8-K 33002
2 EMPLOYMENT AGREEMENT, MADE AND ENTERED INTO AS OF JULY 1, 2022, BY AND BETWEEN A ea171330ex10-1_dominari.htm EX-10.1 61351
3 AMENDMENT TO EMPLOYMENT AGREEMENT, DATED AS OF JANUARY 1, 2023, BY AND BETWEEN D ea171330ex10-2_dominari.htm EX-10.2 11256
  Complete submission text file 0001213900-23-001363.txt   328094

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE domh-20230101.xsd EX-101.SCH 3239
5 XBRL DEFINITION FILE domh-20230101_def.xml EX-101.DEF 26198
6 XBRL LABEL FILE domh-20230101_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE domh-20230101_pre.xml EX-101.PRE 22367
9 EXTRACTED XBRL INSTANCE DOCUMENT ea171330-8k_dominari_htm.xml XML 3597
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
Dominari Holdings Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 23515102
SIC: 2834 Pharmaceutical Preparations